SafePAS in the Spotlight
Estonian deep-tech company SafePAS has been awarded €2.5 million by the Estonian Business and Innovation Agency (EIS) under the European Innovation Council ....
SafePAS, an Estonian deeptech startup transforming the future of drug detection, has raised €700,000 in a pre-seed round led by BSV Ventures, with participation from Prague-based PurposeTech, EstBAN...
sTARTUp Pitching 2025 has once again brought together the most ambitious startups, investors, and ecosystem players to showcase groundbreaking ideas and fierce competition. This year, a record number of startups entered the race,....
We are proud to announce that the Politsei- ja Piirivalveamet with Drug Hunter analyzer are the winners in the category: Innovative Technical Solution. Through leveraging advanced technologies,...
As drug-impaired driving has increased 35% across Europe in the past 5 years. Traditional immunoassay tests produce false positives, require expensive lab confirmation,..
On #WorldFoodDay, day two of Next Bite 2025 brought our community together to reflect on what’s possible when innovation meets collaboration. The conversations in Brussels showed the power of working side by side to build a resilient and sustainable food system.
SafePAS, TalTech Tallinn University of Technology spin-off, has secured a €2.5M Seal-of-Excellence grant to scale our Drug Hunter analyzer!
Estonian deep tech company SafePAS has received a €2.5M grant from the Enterprise and Innovation Fund (EIS) to further develop its DrugHunter rapid drug test. The grant was awarded on the basis of the EIC European Innovation Council's Seal of Excellence.